Examkin

Question

Difficulty: HardGastroenterology and Hepatology

A 58-year-old woman is evaluated in the outpatient clinic for a six-month history of progressive abdominal bloating, frequent flatulence, and chronic watery diarrhea. She also reports a 4.5-kg (10-lb) weight loss over this period despite maintaining a normal appetite. Her past medical history is notable for Raynaud phenomenon and systemic sclerosis, for which she is taking mycophenolate mofetil. Vital signs are within normal limits. Physical examination reveals thickened, tight skin over the fingers and face, as well as mild, diffuse abdominal distension without focal tenderness or organomegaly. Laboratory studies are obtained and reveal the following:

Hemoglobin: 10.4 g/dL
Mean corpuscular volume: 106 fL
Vitamin B12: 120 pg/mL (low)
Folate: 26 ng/mL (abnormally high)

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient's gastrointestinal symptoms?

  1. Carbohydrate breath testingAnswer
  2. B
    Anti-tissue transglutaminase IgA assay
  3. C
    Measurement of fecal elastase
  4. D
    Empiric intravenous piperacillin-tazobactam
  5. E
    Colonoscopy with random mucosal biopsies

Answer

The correct answer is carbohydrate breath testing.
The correct answer is carbohydrate breath testing. This patient's history of systemic sclerosis puts her at high risk for intestinal dysmotility and subsequent stasis. This stasis allows colonic bacteria to migrate and overgrow in the small intestine, leading to Small Intestinal Bacterial Overgrowth (SIBO). The clinical presentation of SIBO includes bloating, flatulence, watery diarrhea, and weight loss. The classic laboratory hallmark of SIBO is a macrocytic anemia characterized by Vitamin B12 deficiency (due to bacterial consumption of dietary B12) and elevated folate levels (due to bacterial synthesis of folate). A carbohydrate breath test (using glucose or lactulose) is the most appropriate non-invasive method to confirm the diagnosis by detecting early peaks in exhaled hydrogen or methane gas.

Step-by-Step Solution

1
Identify the patient's underlying gastrointestinal risk factor.
The patient has systemic sclerosis, which causes smooth muscle atrophy and fibrosis in the gastrointestinal tract, leading to severe intestinal dysmotility.
Recognizing the complication of dysmotility is essential, as stasis in the small bowel predisposes patients to abnormal bacterial proliferation.
2
Interpret the specific laboratory abnormalities.
The patient has a macrocytic anemia with low Vitamin B12 and abnormally high folate levels.
This unique B12/folate dichotomy is the hallmark of Small Intestinal Bacterial Overgrowth (SIBO). Enteric bacteria aggressively consume dietary Vitamin B12 while simultaneously synthesizing and secreting folate into the gut lumen.
3
Determine the optimal diagnostic study for the suspected condition.
Carbohydrate breath testing (using lactulose or glucose) is the preferred next step.
Breath testing non-invasively measures hydrogen and methane gas produced by bacterial fermentation of the ingested carbohydrate load, confirming the diagnosis of SIBO.

Key Concept

Small Intestinal Bacterial Overgrowth (SIBO) presents with malabsorption, low Vitamin B12, and high folate, frequently occurring in patients with altered intestinal motility (e.g., systemic sclerosis).

Alternative Method

While carbohydrate breath testing is the preferred non-invasive approach, the true gold standard for diagnosing SIBO is upper endoscopy with quantitative culture of a jejunal aspirate (showing >10^3 CFU/mL of bacteria). It is rarely performed due to its invasive nature.
Estimated Time:1m 30s
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic